nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Applicability of the EORTC/MSG criteria for IFD in clinical practice
|
Rieger, H. |
|
2014 |
94 |
Suppl 1 |
p. 847-855 |
artikel |
2 |
A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation
|
Sakellari, Ioanna |
|
2015 |
94 |
Suppl 1 |
p. 1733-1740 |
artikel |
3 |
A review of the European LeukemiaNet recommendations for the management of CML
|
Baccarani, Michele |
|
2015 |
94 |
Suppl 1 |
p. 141-147 |
artikel |
4 |
Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice
|
Becker, M. |
|
2015 |
94 |
Suppl 1 |
p. 1553-1558 |
artikel |
5 |
Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide
|
Lau, I-Jun |
|
2014 |
94 |
Suppl 1 |
p. 643-649 |
artikel |
6 |
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States
|
Medeiros, Bruno C. |
|
2015 |
94 |
Suppl 1 |
p. 1127-1138 |
artikel |
7 |
Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients
|
Hochhaus, Andreas |
|
2015 |
94 |
Suppl 1 |
p. 133-140 |
artikel |
8 |
CD4+ T cell counts reflect the immunosuppressive state of CD4 helper cells in patients after allogeneic stem cell transplantation
|
Holtick, Udo |
|
2014 |
94 |
Suppl 1 |
p. 129-137 |
artikel |
9 |
CML—where do we stand in 2015?
|
Hehlmann, Rüdiger |
|
2015 |
94 |
Suppl 1 |
p. 103-105 |
artikel |
10 |
Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients
|
Park, Meerim |
|
|
94 |
Suppl 1 |
p. 481-489 |
artikel |
11 |
Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma
|
Hasegawa, Tetsuo |
|
2014 |
94 |
Suppl 1 |
p. 515-517 |
artikel |
12 |
Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results
|
Cervantes, Francisco |
|
2015 |
94 |
Suppl 1 |
p. 1791-1796 |
artikel |
13 |
Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures
|
Kim, Ji Hyun |
|
2015 |
94 |
Suppl 1 |
p. 1457-1461 |
artikel |
14 |
Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes
|
Mehta, Pallavi R. |
|
2015 |
94 |
Suppl 1 |
p. 1953-1958 |
artikel |
15 |
Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia
|
Jang, Ji Eun |
|
2014 |
94 |
Suppl 1 |
p. 275-282 |
artikel |
16 |
Enhanced human mesenchymal stem cell survival under oxidative stress by overexpression of secreted frizzled-related protein 2 gene
|
Pomduk, Kanjana |
|
2014 |
94 |
Suppl 1 |
p. 319-327 |
artikel |
17 |
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera
|
Cherry, Mohamad |
|
2014 |
94 |
Suppl 1 |
p. 717-719 |
artikel |
18 |
Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
|
Remacha, Ángel F. |
|
2014 |
94 |
Suppl 1 |
p. 779-787 |
artikel |
19 |
Fatal pulmonary hemorrhage after carfilzomib treatment in multiple myeloma
|
Kwong, Yok-Lam |
|
2015 |
94 |
Suppl 1 |
p. 1425-1426 |
artikel |
20 |
First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis
|
Messori, Andrea |
|
2015 |
94 |
Suppl 1 |
p. 1003-1009 |
artikel |
21 |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Hou, Hsin-An |
|
2014 |
94 |
Suppl 1 |
p. 211-221 |
artikel |
22 |
Headache prevalence following recovery from TTP and aHUS
|
Saultz, Jennifer N. |
|
2015 |
94 |
Suppl 1 |
p. 1473-1476 |
artikel |
23 |
Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses
|
Nadir, Yona |
|
2015 |
94 |
Suppl 1 |
p. 1213-1219 |
artikel |
24 |
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)
|
Witte, Theo de |
|
2015 |
94 |
Suppl 1 |
p. 1981-1989 |
artikel |
25 |
Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial
|
Schweitzer, Jana |
|
2015 |
94 |
Suppl 1 |
p. 1327-1336 |
artikel |
26 |
Incidence of testicular microlithiasis in patients with β-thalassemia major
|
Rahimi, Rahil |
|
2015 |
94 |
Suppl 1 |
p. 1785-1789 |
artikel |
27 |
Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT
|
Ak, İlknur |
|
2015 |
94 |
Suppl 1 |
p. 1567-1575 |
artikel |
28 |
Krüppel-like factor 1 mutations and expression of hemoglobins F and A2 in homozygous hemoglobin E syndrome
|
Tepakhan, Wanicha |
|
2015 |
94 |
Suppl 1 |
p. 1093-1098 |
artikel |
29 |
Leishmaniasis involving the bone marrow of a patient with multiple myeloma
|
Alahmadi, M. |
|
2015 |
94 |
Suppl 1 |
p. 1417-1418 |
artikel |
30 |
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes
|
Schwaab, Juliana |
|
2014 |
94 |
Suppl 1 |
p. 233-238 |
artikel |
31 |
Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome
|
Qiao, Jianlin |
|
2015 |
94 |
Suppl 1 |
p. 2069-2071 |
artikel |
32 |
Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemia
|
Rea, Delphine |
|
2015 |
94 |
Suppl 1 |
p. 149-158 |
artikel |
33 |
Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis
|
Kogure, Yasunori |
|
2015 |
94 |
Suppl 1 |
p. 989-994 |
artikel |
34 |
Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient
|
Taguchi, Masataka |
|
2014 |
94 |
Suppl 1 |
p. 693-695 |
artikel |
35 |
Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization
|
Cross, Nicholas C. P. |
|
2015 |
94 |
Suppl 1 |
p. 219-225 |
artikel |
36 |
Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience
|
Chakupurakal, G. |
|
2015 |
94 |
Suppl 1 |
p. 1717-1725 |
artikel |
37 |
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial
|
Wasle, Ines |
|
2014 |
94 |
Suppl 1 |
p. 593-601 |
artikel |
38 |
Oral beclomethasone dipropionate as an initial treatment for stages 1–2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation
|
Yamamoto, Hisashi |
|
2015 |
94 |
Suppl 1 |
p. 2073-2075 |
artikel |
39 |
Osteopontin: a potential biomarker of Gaucher disease
|
Vairo, Filippo |
|
2015 |
94 |
Suppl 1 |
p. 1119-1125 |
artikel |
40 |
Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma
|
Higo, Takashi |
|
2014 |
94 |
Suppl 1 |
p. 683-685 |
artikel |
41 |
Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation
|
Yano, Shingo |
|
2014 |
94 |
Suppl 1 |
p. 491-496 |
artikel |
42 |
Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings
|
Czuczman, Myron S. |
|
2015 |
94 |
Suppl 1 |
p. 2025-2032 |
artikel |
43 |
Prediction of central venous catheter–related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS)
|
Schalk, Enrico |
|
2015 |
94 |
Suppl 1 |
p. 1451-1456 |
artikel |
44 |
Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome
|
Piekarska, Agnieszka |
|
2015 |
94 |
Suppl 1 |
p. 1891-1897 |
artikel |
45 |
Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy
|
Rovira, Jordina |
|
2014 |
94 |
Suppl 1 |
p. 803-812 |
artikel |
46 |
Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis
|
Yi-ning, Yang |
|
2015 |
94 |
Suppl 1 |
p. 929-938 |
artikel |
47 |
Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma
|
Paydas, Semra |
|
2015 |
94 |
Suppl 1 |
p. 1545-1552 |
artikel |
48 |
Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab
|
Berinstein, N. L. |
|
2015 |
94 |
Suppl 1 |
p. 813-823 |
artikel |
49 |
Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 109/L monoclonal lymphocytes better identifies subgroups with different outcomes
|
Oliveira, A. C. |
|
2014 |
94 |
Suppl 1 |
p. 627-632 |
artikel |
50 |
Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial
|
Han, Ting-ting |
|
2014 |
94 |
Suppl 1 |
p. 117-128 |
artikel |
51 |
Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
|
Giordano, Paola |
|
2015 |
94 |
Suppl 1 |
p. 1765-1776 |
artikel |
52 |
Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
|
Zhang, Xiaohui |
|
2014 |
94 |
Suppl 1 |
p. 837-845 |
artikel |
53 |
Repurposing medicinal compounds for blood cancer treatment
|
McCabe, Bronagh |
|
2015 |
94 |
Suppl 1 |
p. 1267-1276 |
artikel |
54 |
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma
|
Czuczman, Myron S. |
|
2015 |
94 |
Suppl 1 |
p. 633-641 |
artikel |
55 |
Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
|
Park, Byeong-Bae |
|
2015 |
94 |
Suppl 1 |
p. 1845-1851 |
artikel |
56 |
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation
|
Koren-Michowitz, Maya |
|
2014 |
94 |
Suppl 1 |
p. 375-378 |
artikel |
57 |
Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma
|
Hara, Masaki |
|
2014 |
94 |
Suppl 1 |
p. 603-608 |
artikel |
58 |
Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment
|
Plander, Mark |
|
2015 |
94 |
Suppl 1 |
p. 1257-1258 |
artikel |
59 |
Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation—a single center experience
|
Heinicke, Thomas |
|
2014 |
94 |
Suppl 1 |
p. 283-287 |
artikel |
60 |
Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy
|
Pokuri, Venkata K. |
|
2015 |
94 |
Suppl 1 |
p. 1067-1068 |
artikel |
61 |
Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation
|
Tschan-Plessl, A. |
|
2015 |
94 |
Suppl 1 |
p. 1899-1905 |
artikel |
62 |
The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China
|
Li, Xiaoyang |
|
2014 |
94 |
Suppl 1 |
p. 57-63 |
artikel |
63 |
The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation
|
Sun, Yu-Qian |
|
2015 |
94 |
Suppl 1 |
p. 1699-1705 |
artikel |
64 |
The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type
|
Chen, Kai-Lin |
|
2015 |
94 |
Suppl 1 |
p. 1389-1400 |
artikel |
65 |
The treatment outcome of multiple myeloma patients ineligible for hematopoietic transplantation—a single institutional experience in Taiwan
|
Huang, Tzu-Chuan |
|
|
94 |
Suppl 1 |
p. 107-115 |
artikel |
66 |
Torsade de Pointes during oral arsenic trioxide therapy for acute promyelocytic leukemia in a patient with heart failure
|
Hai, Jo Jo |
|
2014 |
94 |
Suppl 1 |
p. 501-503 |
artikel |
67 |
Trained clinical nurse specialists proficiently obtain bone marrow aspirates and trephine biopsies in a nearly painless procedure—a prospective evaluation study
|
Naegele, M. |
|
2015 |
94 |
Suppl 1 |
p. 1577-1584 |
artikel |
68 |
Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings
|
Tischer, Johanna |
|
2015 |
94 |
Suppl 1 |
p. 1677-1688 |
artikel |